Colombia Vaccines Market Overview, 2028

Colombia Vaccines Market Overview, 2028

Colombia places a strong emphasis on vaccination as a public health priority. The government actively promotes and supports vaccination programmes, aiming to ensure that a significant portion of the population is immunised against vaccine-preventable diseases. Colombia has established comprehensive national vaccination programmes, including the Expanded Programme on nation. These programmes provide a framework for delivering vaccines to various age groups, from infants to older adults. The Colombian government strives to make vaccines accessible to all citizens, regardless of socioeconomic status or geographic location. Vaccination services are provided through a network of healthcare facilities, public clinics, and vaccination campaigns, ensuring that vaccines are within reach for most Colombians. Public health campaigns and educational initiatives play a significant role in shaping the culture around vaccination in Colombia. These efforts aim to inform the public about the importance of vaccines, address vaccine hesitancy, and combat misinformation. Colombia has implemented vaccine mandates for specific age groups, such as children entering school. These mandates encourage parents to ensure that their children receive recommended vaccines, contributing to high vaccine coverage rates. Vaccination is generally accepted and well-regarded in Colombian society. Many Colombians view vaccination as a means of protecting their families and communities from preventable diseases. This cultural acceptance contributes to high vaccine uptake. Colombian healthcare providers, including doctors and nurses, are trusted sources of information and recommendations regarding vaccines. Their guidance and recommendations are highly influential in patients' decisions to vaccinate.

According to the research report, ""Columbia Vaccines Market Outlook, 2028,"" published by Bonafide Research, the Colombia Vaccines market is anticipated to reach around USD 474 Million by 2028. The Colombian government has demonstrated a strong commitment to public health and vaccination. Government initiatives prioritise vaccination as a fundamental healthcare intervention, promoting widespread vaccine coverage. Community health workers and healthcare professionals actively engage with communities to provide information and address concerns related to vaccination. Their efforts help build trust and confidence in vaccines. Healthcare providers, including doctors, nurses, and pharmacists, are trusted sources of information and recommendations regarding vaccines. Their guidance and endorsements play a significant role in encouraging patients to get vaccinated. Colombia's improving economic conditions have contributed to increased healthcare investments, including vaccine procurement and distribution, fostering the growth of the vaccine market. The Colombian government has implemented vaccine mandates for specific age groups, such as school entry requirements. These mandates have contributed to high vaccine coverage rates among children. Vaccination is culturally accepted in Colombia and viewed as a means of safeguarding individuals, families, and communities from preventable diseases. It is culturally accepted in Colombia and viewed as a means of safeguarding individuals, families, and communities from preventable diseases. The Colombian government's strong commitment to public health and vaccination programmes underscores the importance of vaccines in disease prevention.

According to the report, the technology is segmented into conjugate vaccines, inactivated and subunit vaccines, live-attenuated vaccines, recombinant vaccines, and toxoid vaccines. In Colombia, conjugate vaccines are the leading technology type. Conjugate vaccines are highly effective in preventing bacterial infections caused by encapsulated bacteria, including Streptococcus pneumoniae, Haemophilus influenzae type b (Hib), and Neisseria meningitidis. These vaccines have been instrumental in reducing the incidence of severe diseases such as pneumonia, meningitis, and sepsis in Colombia's population, especially among infants and young children. The Colombian government has prioritised the inclusion of conjugate vaccines in its national immunisation program. These vaccines are often recommended and administered to children as part of routine immunisation schedules, contributing to high vaccine coverage rates. Government support ensures that these vaccines are accessible and affordable for the entire population. Conjugate vaccines have gained public trust in Colombia due to their proven efficacy and the government's endorsement. Public health campaigns and educational initiatives reinforce the importance of these vaccines, contributing to parental confidence in their children's immunisation.

Based on the route of administration, they are segmented into intramuscular and subcutaneous administration, oral administration, and others. In this country, intramuscular and subcutaneous injections lead the market. Intramuscular and subcutaneous injections are well-established and proven methods for vaccine delivery. They are known to elicit a strong and effective immune response, which is essential for the prevention of vaccine-preventable diseases. Colombia has a well-developed routine immunisation programme that recommends a schedule of vaccinations for various age groups. Many of these vaccines are traditionally administered via IM or SC injection. Colombia has a robust healthcare infrastructure with trained healthcare professionals who are skilled in administering vaccines through IM and SC routes. This infrastructure supports efficient vaccine delivery. Many vaccines in Colombia, including routine childhood vaccines, are designed for IM or SC administration. These vaccines protect against diseases such as diphtheria, tetanus, pertussis, polio, hepatitis, and influenza. According to the report, types are segmented into multivalent vaccines and monovalent vaccines among them in Colombia. Monovalent vaccines are a growing market. Some diseases require dedicated monovalent vaccines due to their unique characteristics or the need for specific antigen formulations. Monovalent vaccines are designed to provide protection against a single pathogen or disease. In cases where a particular disease is of significant concern in Colombia, the use of monovalent vaccines targeting that disease can be a priority. Changes in disease epidemiology or the emergence of new disease threats can drive the demand for monovalent vaccines. If a specific disease becomes more prevalent or poses a particular risk in Colombia, there may be a need for dedicated monovalent vaccines to address that threat.

In terms of disease types, they include the rotavirus, pneumococcal diseases, cancer, influenza, diphtheria, pertussis, and tetanus, the human papilloma virus (HPV), hepatitis, shingles, meningococcal diseases, varicella, mumps, and others. Influenza is a seasonal respiratory illness that can lead to significant morbidity and mortality, especially among vulnerable populations. The seasonal nature of influenza necessitates annual vaccination, which contributes to the consistent demand for influenza vaccines. Colombian public health authorities often run annual influenza vaccination campaigns to encourage the population, especially high-risk groups like the elderly, young children, and individuals with underlying health conditions, to get vaccinated. Colombia has a well-developed healthcare infrastructure that allows for the efficient distribution and administration of influenza vaccines across the country. The Colombian government may provide support for influenza vaccination campaigns, including funding, vaccine procurement, and awareness campaigns, to ensure widespread access and coverage.

Based on the end user segment, which includes paediatric vaccines and adult vaccines, in Colombia, adult vaccines are a growing market. Colombia has a growing emphasis on preventive healthcare, and vaccination is seen as a fundamental aspect of disease prevention. This preventive healthcare culture encourages adults to stay up-to-date with recommended vaccines to protect themselves and their communities. Colombia, like many countries, is grappling with an increasing burden of chronic diseases such as diabetes, heart disease, and respiratory conditions. Vaccination against diseases like influenza and pneumonia is essential for adults with underlying health conditions to prevent complications and hospitalizations. Colombia's status as a tourist destination and its citizens' travel abroad contribute to the demand for travel vaccines among adults. Travellers often require vaccinations to protect against diseases prevalent in their destination countries. Vaccinating adults helps maintain a healthy and productive workforce, reducing absenteeism due to illness. Healthy adults can contribute more effectively to the country's economy.

Distribution channels include hospital pharmacy, retail pharmacy, institutional sales, and others. In Colombia, the retail pharmacy market is growing. The general public may readily access retail pharmacies because of their many locations in both urban and rural regions. It is convenient for people to get immunisations without a doctor's visit thanks to this accessibility and expanded operation hours. Pharmacies are often situated within or near communities, making them a trusted and familiar healthcare resource for local residents. People are more likely to seek vaccination services in familiar settings. Pharmacists are respected healthcare professionals, and their involvement in vaccine distribution instills confidence in the safety and effectiveness of vaccines. Many individuals trust their pharmacist's recommendations regarding vaccination. The Colombian government has recognised the potential of retail pharmacies to expand vaccine access. Collaborative efforts between government agencies and pharmacy associations have facilitated the inclusion of pharmacies in vaccination programs. Retail pharmacies may offer competitive pricing for vaccines, making them an attractive option for individuals who are concerned about vaccine costs.

Considered in this report:
• Geography: Colombia
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Colombia Vaccines market Outlook with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Technology
• Conjugate vaccines
• Inactivated & Subunit vaccines
• Live Attenuated vaccines
• Recombinant vaccines
• Toxoid vaccines
• Viral vector vaccines
• Others

By Route of Administration
• Intramuscular and Subcutaneous Administration
• Oral Administration
• Others

By Disease
• Rotavirus
• Pneumococcal diseases
• Cancer
• Influenza
• Diphtheria, Pertussis, and Tetanus (DTP)
• Human Papilloma Virus (HPV)
• Hepatitis
• Shingles
• Meningococcal diseases
• Varicella (Chicken Pox)
• Mumps
• Others

By Type
• Multivalent vaccines
• Monovalent vaccines

By End-User Type
• Paediatrics
• Adults

By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Drone industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.